Fibroblast growth factor-2 binding to the endothelial basement membrane peaks at a physiologically relevant shear stress

Matrix Biology

Volumn 29, Issue 7, 2010, Pages 586-593

  Reisig, Karl ^a   Clyne, Alisa Morss ^b  

^a DREXEL UNIVERSITY   (United States)

^b Drexel University   (United States)

Author keywords

Basement membrane; Binding kinetics; Fibroblast growth factor 2; Growth factor; Heparan sulfate proteoglycans; Shear stress

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BINDING SITE; CONTROLLED STUDY; FLUID FLOW; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SHEAR STRESS;

ANIMALS; BASEMENT MEMBRANE; BINDING SITES; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GLASS; HEPARAN SULFATE PROTEOGLYCANS; KINETICS; MICROSCOPY, PHASE-CONTRAST; PROTEIN BINDING; RHEOLOGY; SUS SCROFA;

EID: 77957752219     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2010.07.003     Document Type: Article

References (48)

1. Alon R., Hammer D., et al. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 1995, 374:539-542.
2. Bashkin P., Doctrow S., et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989, 28:1737-1743.
3. Bell G.I. Model for the specific adhesion of cells to cells. Science 1978, 200(4342):618-627.
4. Bikfalvi A., Klein S., et al. Biological roles of fibroblast growth factor-2. Endocr. Rev. 1997, 18(1):26-45.
5. Caputo K.E., Lee D., et al. Adhesive dynamics simulations of the shear threshold effect for leukocytes. Biophys. J. 2007, 92(3):787-797.
6. Chen S., Springer T.A. Selectin receptor-ligand bonds: formation limited by shear rate and dissociation governed by the Bell model. Proc. Natl Acad. Sci. USA 2001, 98(3):950-955.
7. Chua C.C., Rahimi N., et al. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ. Res. 2003, 94:316-323.
8. Cordon-Cardo C., Vlodavsky I., et al. Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest. 1990, 63(6):832-840.
9. Dembo M. The reaction-limited kinetics of membrane-to-surface adhesion and detachment. Proc. R. Soc. Lond. B Biol. Sci. 1988, 234:55-83.
10. Doggett T.A., Girdhar G., et al. Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIbalpha-vWF tether bond. Biophys. J. 2002, 83:194-205.
11. Dowd C., Cooney C., et al. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J. Biol. Chem. 1999, 274(8):5236-5244.
12. Fannon M., Forsten K.E., et al. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response†. Biochemistry 2000, 39(6):1434-1445.
13. Finger E., Puri K., et al. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature 1996, 379(6562):266-270.
14. Fingerle J., Au Y., et al. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arterioscler. Thromb. Vasc. Biol. 1990, 10(6):1082-1087.
15. Forsten-Williams K., Chua C.C., et al. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J. Theor. Biol. 2005, 233:483-499.
16. Gajdusek C.M., Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J. Cell. Physiol. 1989, 139(3):570-579.
17. Laham R.J., Rezaee M., et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J. Pharmacol. Exp. Ther. 2000, 292(2):795-802.
18. Laham R.J., Sellke F.W., et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999, 100(18):1865-1871.
19. Lawrence M., McIntire L., et al. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood 1987, 70(5):1284-1290.
20. Lindner V. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl Acad. Sci. USA 1991, 88:3739-3743.
21. Lindner V., Reidy M. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ. Res. 1993, 73(3):589-595.
22. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 1996, 134(2):529-536.
23. Malek A.M., Alper S.L., et al. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999, 282(21):2035-2042.
24. Marshall B.T., Long M., et al. Direct observation of catch bonds involving cell-adhesion molecules. Nature 2003, 423(6936):190-193.
25. Montesano R., Vassalli J.-D., et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA 1986, 83:7297-7301.
26. Morss-Clyne A., Edelman E.R. Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding. Cytotechnology 2009, 60:33-44.
27. Morss A. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J. Biol. Chem. 2007, 282(17):14635-14644.
28. Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 1987, 131(1):123-130.
29. Neufeld G., Gospodarowicz D. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 1985, 260(25):13860-13868.
30. Nugent M.A., Edelman E.R. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 1992, 31:8876-8883.
31. Pereverzev Y.V., Prezhdo O.V., et al. The Two-pathway model for the catch-slip transition in biological adhesion. Biophys. J. 2005, 89(3):1446-1454.
32. Rapraeger A.C., Alison K., et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252(5013):1705-1708.
33. Rapraeger A.C., Krufka A., et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. (basic fibroblast growth factor). Science 1991, v252(5013):1705-1709.
34. Rhoads D.N., Eskin S.G., et al. Fluid flow releases fibroblast growth factor-2 from human aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20:416-421.
35. Saksela O., Moscatelli D., et al. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 1988, 107:743-751.
36. Schumacher B., Pecher P., et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998, 97(7):645-650.
37. Shen W., Zhang C., et al. A computational model of FGF-2 binding and HSPG regulation under flow. IEEE Trans. Biomed. Eng. 2007, 6(1):1-9.
38. Sperinde G.V., Nugent M.A. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells†. Biochemistry 1998, 37(38):13153-13164.
39. Takalkar A.M., Klibanov A.L., et al. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J. Control. Release 2004, 96(3):473-482.
40. Thomas W.E., Nilsson L.M., et al. Shear-dependent 'stick-and-roll' adhesion of type 1 fimbriated Escherichia coli. Mol. Microbiol. 2004, 53(5):1545-1557.
41. Thomas W.E., Trintchina E., et al. Bacterial adhesion to target cells enhanced by Shear Force. Cell 2002, 109(7):913-923.
42. Villaschi S., Nicosia R. Angiogenic role of endogenic basic fibroblast growth factor release by rat aorta after injury. Am. J. Pathol. 1993, 143(1):181-190.
43. Vlodavsky I. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl Acad. Sci. USA 1987, 84:2292-2296.
44. Vlodavsky I., Folkman J., et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl Acad. Sci. USA 1987, 84:2292-2296.
45. Vlodavsky I., Fridman R., et al. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J. Cell. Physiol. 1987, 131(3):402-408.
46. Wong M.K.K., Gotlieb A.I. In vitro reendothelialization of a single wound: role of microfilament bundles in rapid lamellipodia mediated wound closure. Lab. Invest. 1984, 51:75-81.
47. Yago T., Wu J., et al. Catch bonds govern adhesion through L-selectin at threshold shear. J. Cell Biol. 2004, 166(6):913-923.
48. Yayon A., Klagsbrun M., et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64(4):841-848.